Ledger.Open graph →

SEC Form D · filed December 26, 2023

Biolinq Inc

Offering

$50.0M

Sold

$35.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN DIEGO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Thad Johnson · SAN DIEGO, CADirector Derek Rapp · SAN DIEGO, CADirector Richard Yang · SAN DIEGO, CAExec · Director David A. Arida · SAN DIEGO, CAExec Jared A. Tangney · SAN DIEGO, CAExec Dan Bradbury · SAN DIEGO, CADirector Chris Dimitropoulos · SAN DIEGO, CADirector Derek Rapp · SAN DIEGO, CADirector Chris Dimitropoulos · SAN DIEGO, CADirector Richard Yang · SAN DIEGO, CAExec · Director Jared A. Tangney · SAN DIEGO, CAExec David A. Arida · SAN DIEGO, CAExec Dan Bradbury · SAN DIEGO, CADirector Thad Johnson · SAN DIEGO, CADirector Sunil Chhaya · Palo Alto, CAExec Philip Cockriel · Arlington, TXDirector Mark J. Pate · KNOXVILLE, TNExec George Bashforth · Grand Cayman, Cayman IslandsDirector Jeffrey M. Smith · San Francisco, CADirector Stepchange Fund I GP, LLC · Seattle, WAExec · Director Armaan Ali · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗